These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34293118)

  • 1. Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever.
    Kharouf F; Ishay Y; Kenig A; Bitan M; Ben-Chetrit E
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI85-SI89. PubMed ID: 34293118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 on familial Mediterranean fever: a nationwide study.
    Günendi Z; Yurdakul FG; Bodur H; Cengiz AK; Uçar Ü; Çay HF; Şen N; Keskin Y; Gürer G; Melikoğlu MA; Altıntaş D; Deveci H; Baykul M; Nas K; Çevik R; Karahan AY; Toprak M; Ketenci S; Nayimoğlu M; Sezer İ; Demir AN; Ecesoy H; Duruöz MT; Yurdakul OV; Sarıfakıoğlu AB; Ataman Ş
    Rheumatol Int; 2021 Aug; 41(8):1447-1455. PubMed ID: 34032894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients.
    Kaya Akca U; Sener S; Balık Z; Gurlevik S; Oygar PD; Atalay E; Cuceoglu MK; Basaran O; Batu ED; Teksam O; Bilginer Y; Ozsurekci Y; Ozen S
    Mod Rheumatol; 2022 Feb; 32(2):467-472. PubMed ID: 34897503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study.
    Güven SC; Erden A; Karakaş Ö; Armağan B; Usul E; Omma A; Küçükşahin O
    Rheumatol Int; 2021 Apr; 41(4):715-719. PubMed ID: 33611656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.
    Avanoglu Guler A; Yuce Inel T; Kasifoglu T; Coskun C; Karadeniz H; Yildirim D; Bilici R; Satis H; Kucuk H; Haznedaroglu S; Goker B; Ozturk MA; Sari I; Tufan A
    Mod Rheumatol; 2023 Jul; 33(4):786-791. PubMed ID: 35860978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review.
    Nas K; Eryilmaz N; Geyik MF; Altaş A
    Rheumatol Int; 2021 Apr; 41(4):811-817. PubMed ID: 33611657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
    J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Mediterranean Fever and COVID-19: Friends or Foes?
    Stella A; Lamkanfi M; Portincasa P
    Front Immunol; 2020; 11():574593. PubMed ID: 33072117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's disease‬ and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study‬.
    Watad A; Tiosano S; Yahav D; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
    Eur J Intern Med; 2017 Apr; 39():75-78. PubMed ID: 27776949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and cardiovascular disease in familial Mediterranean fever. An analysis of hospital admissions for acute cardiovascular event.
    Roitman A; Ben-Zvi I; Mendel L; Livneh A
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):80-85. PubMed ID: 30299242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Mediterranean fever-associated infertility and underlying factors.
    Atas N; Armagan B; Bodakci E; Satis H; Sari A; Bilge NSY; Salman RB; Yardımcı GK; Babaoglu H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kasifoglu T; Kalyoncu U; Tufan A
    Clin Rheumatol; 2020 Jan; 39(1):255-261. PubMed ID: 31502094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever.
    Marinelli F; Caporilli C; Titolo A; Rigante D; Esposito S
    Pharmacol Res; 2022 Aug; 182():106293. PubMed ID: 35690330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Mediterranean fever: an association with non-alcoholic fatty liver disease.
    Rimar D; Rosner I; Rozenbaum M; Zuckerman E
    Clin Rheumatol; 2011 Jul; 30(7):987-91. PubMed ID: 21360101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semen analysis in adolescents with familial Mediterranean fever.
    Kaya Aksoy G; Koyun M; Usta MF; Çomak E; Akman S
    J Pediatr Urol; 2019 Aug; 15(4):342.e1-342.e7. PubMed ID: 31036478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased vitamin D levels in children with familial Mediterranean fever.
    Anık A; Catlı G; Makay B; Abacı A; Küme T; Unsal E; Böber E
    Int J Rheum Dis; 2014 Mar; 17(3):321-6. PubMed ID: 24410734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence.
    Giese A; Kurucay M; Kilic L; Örnek A; Şendur SN; Lainka E; Henning BF
    Rheumatol Int; 2013 Jul; 33(7):1713-9. PubMed ID: 23274441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Goker B; Tufan A; Haznedaroglu S
    J Clin Rheumatol; 2020 Jan; 26(1):7-13. PubMed ID: 30048391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal arterial stiffness in familial Mediterranean fever. Evidence for a possible cardiovascular protective role of colchicine.
    Kukuy O; Livneh A; Mendel L; Benor A; Giat E; Perski O; Feld O; Kassel Y; Ben-Zvi I; Lidar M; Holtzman EJ; Leiba A
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):32-37. PubMed ID: 28229824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.